Synthetic serine protease inhibitor, Gabexate mesilate, prevents nuclear Factor-κB activation and increases TNF-α-Mediated apoptosis in human pancreatic cancer cells
Synthetic serine protease inhibitor, Gabexate mesilate, prevents nuclear Factor-κB activation and increases TNF-α-Mediated apoptosis in human pancreatic cancer cells
复制标题
DOI:
10.1007/s10620-006-9654-7
复制
发表时间:
2007-10-01
影响因子:
3.1
通讯作者:
Manabe, Tadao
中科院分区:
文献类型:
--
作者:
Takahashi, Hiroki;Funahashi, Hitoshi;Manabe, Tadao
Gabexate mesilate ( GM), a synthetic serine protease inhibitor, suppresses nuclear factor-kappa B (NF-kappa B) activity in human monocytes or human umbilical vein endothelial cells (HUVECs). In this study we examine whether GM also suppresses NF-kappa B activation and induces apoptosis in human pancreatic cancer cell lines. The addition of tumor necrosis factor alpha (TNF-alpha) did not change the rates of growth of BxPC-3 and MIA PaCa-2. However, in the presence of GM and TNF-alpha, proliferation decreased in a dose-dependent manner. GM- and TNF-alpha-treated cells exhibited morphologic changes indicative of apoptosis, including chromatin condensation and nuclear fragmentation. The NF-kappa Bactivity of both cell lines was increased by the addition of TNF-alpha, while TNF-alpha-induced NF-kappa B activity was suppressed by prestimulation with GM in a dose-dependent manner. Caspase 3 and 7 activity was significantly increased by TNF-alpha with GM stimulation. Furthermore, GM also suppressed the invasive potential of both cell lines. These results indicate that GM inhibits TNF-alpha-induced NF-kappa B activation and enhances apoptosis in human pancreatic cancer cell lines.